Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 14, 2024
Safety and efficacy of inclisiran in treating hypercholesterolemia: A systemic review and meta-analysisZhiling Cheng, Meiling Gao, Yang Liu, et al.Toxicology Letters|June 9, 2022
Downregulation of hERG channel expression by tyrosine kinase inhibitors nilotinib and vandetanib predominantly contributes to arrhythmogenesisXiaoyan Cui, Jinglei Sun, Congxin Li, et al.Acta Biomaterialia|October 6, 2012
Gene delivery of PEI incorporating with functional block copolymer via non-covalent assembly strategyYuling Hu, Dezhong Zhou, Congxin Li, et al.Chemical Communications (Cambridge, England)|April 5, 2012
The effects of a multifunctional oligomer and its incorporation strategies on the gene delivery efficiency of poly(L-lysine)Dezhong Zhou, Congxin Li, Yuling Hu, et al.Scientific Reports|May 7, 2025
Effects of the mitoxantrone thermosensitive liposome nanodelivery system on prostate cancer in vivo and in vitroYuan Gao, Tianjiao Wen, Bin Shan, et al.International Journal of Biological Macromolecules|March 7, 2012
Glycopolymer modification on physicochemical and biological properties of poly(L-lysine) for gene deliveryDezhong Zhou, Congxin Li, Yuling Hu, et al.ACS Nano|February 13, 2020
Fluorine Doped Cagelike Carbon Electrocatalyst: An Insight into the Structure-Enhanced CO Selectivity for CO<sub>2</sub> Reduction at High OverpotentialWei Ni, Yifei Xue, Xiaogang Zang, et al.Chemical Communications (Cambridge, England)|April 30, 2020
Magnesium oxide anchored into a hollow carbon sphere realizes synergistic adsorption and activation of CO<sub>2</sub> for electrochemical reductionCongxin Li, Wei Ni, Xiaogang Zang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 22, 2011
A novel glutathione modified chitosan conjugate for efficient gene deliveryCongxin Li, Tianying Guo, Dezhong Zhou, et al.Drug Design, Development and Therapy|May 18, 2026
GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR PathwayYunsheng Xu, Yanan Li, Zhiling Cheng, et al.Pageof 5